Lates News

In the Hong Kong stock market, the innovative pharmaceutical sector opened lower. GALE Pharmaceutical-B fell more than 8%, BeiGene and China Biologic Products both fell more than 7%, and Chi-Med, Pharmaron and 3SBio all declined.